Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
oxygen inhalation
Adaptive optics imaging
Locations
1
United States
Food and Drug Administration
Silver Spring, Maryland, United States
Start Date
January 22, 2018
Primary Completion Date
September 30, 2026
Completion Date
September 30, 2026
Last Updated
April 3, 2025
NCT03675412
NCT06053307
NCT02796560
NCT01853085
NCT03800589
NCT03067415
Lead Sponsor
Food and Drug Administration (FDA)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions